{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:01:54Z","timestamp":1792555314547,"version":"4.5.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objective<\/jats:title>\n                    <jats:p>Calcific uremic arteriolopathy (CUA) is an often fatal condition with no effective treatment. Multiple case reports and case series have described intravenous sodium thiosulfate (STS) administration in CUA, but no studies have systematically evaluated this treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, participants, &amp; measurements<\/jats:title>\n                    <jats:p>This study included 172 patients undergoing maintenance hemodialysis who had CUA and were treated with STS between August 2006 and June 2009 at Fresenius Medical Care North America. Of these, 85% completed STS therapy. Clinical, laboratory, and mortality data were abstracted from clinical information systems. Responses to survey questionnaires sent to treating physicians regarding patient-level outcomes were available for 53 patients. Effect on CUA lesions and mortality were summarized as CUA outcomes. Relevant laboratory measures, weight (using pairwise comparisons of values before, during, and after STS), and adverse events were summarized as safety parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Mean age of the cohort was 55 years, and 74% of patients were women. Median STS dose was 25 g, and median number of doses was 38. Among surveyed patients, CUA completely resolved in 26.4%, markedly improved in 18.9%, improved in 28.3%, and did not improve in 5.7%; in the remaining patients (20.8%), the response was unknown. One-year mortality in patients treated with STS was 35%. Adverse events, laboratory abnormalities, and weight-related changes were mild. Significant reductions in serum phosphorous (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.02) and parathyroid hormone (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.01) were noted during STS treatment in patients who completed the therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although conclusive evidence regarding its efficacy is lacking, a majority of patients who received STS demonstrated clinical improvement in this study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.09880912","type":"journal-article","created":{"date-parts":[[2013,3,21]],"date-time":"2013-03-21T23:27:28Z","timestamp":1363908448000},"page":"1162-1170","source":"Crossref","is-referenced-by-count":195,"title":["Sodium Thiosulfate Therapy for Calcific Uremic Arteriolopathy"],"prefix":"10.2215","volume":"8","author":[{"given":"Sagar U.","family":"Nigwekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Brunelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Meade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Hymes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Lacson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20230811","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1525-139X.2002.00052.x","article-title":"Calciphylaxis: Emerging concepts in prevention, diagnosis, and treatment.","volume":"15","author":"Wilmer","year":"2002","journal-title":"Semin Dial"},{"key":"R2-15-20230811","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11255-008-9373-4","article-title":"Calciphylaxis: Calcific uremic arteriolopathy and the emerging role of sodium thiosulfate.","volume":"40","author":"Hayden","year":"2008","journal-title":"Int Urol Nephrol"},{"key":"R3-15-20230811","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2215\/CJN.00530108","article-title":"Calciphylaxis from nonuremic causes: A systematic review.","volume":"3","author":"Nigwekar","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R4-15-20230811","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/SMJ.0b013e3180f6100c","article-title":"An unusual case of nonhealing leg ulcer in a diabetic patient.","volume":"100","author":"Nigwekar","year":"2007","journal-title":"South Med J"},{"key":"R5-15-20230811","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1681\/ASN.V77978","article-title":"Calciphylaxis in chronic renal failure.","volume":"7","author":"Budisavljevic","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"R6-15-20230811","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0039-6060(97)90212-9","article-title":"Calciphylaxis in patients on hemodialysis: A prevalence study.","volume":"122","author":"Angelis","year":"1997","journal-title":"Surgery"},{"key":"R7-15-20230811","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1056\/NEJMcpc069038","article-title":"Case records of the Massachusetts General Hospital. Case 7-2007. A 59-year-old woman with diabetic renal disease and nonhealing skin ulcers.","volume":"356","author":"Bazari","year":"2007","journal-title":"N Engl J Med"},{"key":"R8-15-20230811","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1046\/j.1523-1755.2002.00375.x","article-title":"Calciphylaxis is usually non-ulcerating: Risk factors, outcome and therapy.","volume":"61","author":"Fine","year":"2002","journal-title":"Kidney Int"},{"key":"R9-15-20230811","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaad.2006.08.065","article-title":"Calciphylaxis: natural history, risk factor analysis, and outcome.","volume":"56","author":"Weenig","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R10-15-20230811","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5301\/JN.2011.6366","article-title":"Calciphylaxis: A still unmet challenge.","volume":"24","author":"Brandenburg","year":"2011","journal-title":"J Nephrol"},{"key":"R11-15-20230811","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/ndt\/gfm676","article-title":"Proximal calciphylaxis treated with calcimimetic \u2018Cinacalcet\u2019.","volume":"23","author":"Mohammed","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R12-15-20230811","doi-asserted-by":"crossref","first-page":"238","DOI":"10.5414\/CNP58238","article-title":"Distal calcific uremic arteriolopathy in a hemodialysis patient responds to lowering of Ca x P product and aggressive wound care.","volume":"58","author":"Russell","year":"2002","journal-title":"Clin Nephrol"},{"key":"R13-15-20230811","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2310\/7750.2011.10052","article-title":"Calcific uremic arteriolopathy treated with cinacalcet, paricalcitol, and autologous growth factors.","volume":"15","author":"Kakagia","year":"2011","journal-title":"J Cutan Med Surg"},{"key":"R14-15-20230811","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4103\/0022-3859.74291","article-title":"Calcific uremic arteriolopathy while on cinacalcet.","volume":"57","author":"Gonzalez-Parra","year":"2011","journal-title":"J Postgrad Med"},{"key":"R15-15-20230811","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1053\/j.ajkd.2004.03.018","article-title":"Successful treatment of calciphylaxis with intravenous sodium thiosulfate.","volume":"43","author":"Cicone","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R16-15-20230811","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2215\/CJN.10241110","article-title":"Sodium thiosulfate pharmacokinetics in hemodialysis patients and healthy volunteers.","volume":"6","author":"Farese","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R17-15-20230811","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1159\/000332221","article-title":"Evolution of treatment strategies for calciphylaxis.","volume":"34","author":"Ross","year":"2011","journal-title":"Am J Nephrol"},{"key":"R18-15-20230811","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/11587060-000000000-00000","article-title":"Treatment of cutaneous calciphylaxis with sodium thiosulfate: Two case reports and a review of the literature.","volume":"12","author":"Auriemma","year":"2011","journal-title":"Am J Clin Dermatol"},{"key":"R19-15-20230811","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000092290","article-title":"Sodium thiosulphate as a promising therapeutic option to treat calciphylaxis.","volume":"212","author":"Meissner","year":"2006","journal-title":"Dermatology"},{"key":"R20-15-20230811","first-page":"1065","article-title":"Use of sodium thiosulfate in the treatment of calciphylaxis.","volume":"20","author":"Musso","year":"2009","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R21-15-20230811","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/0886022X.2010.536288","article-title":"Sodium thiosulfate not always resolves calciphylaxis: An ambiguous response.","volume":"33","author":"Miceli","year":"2011","journal-title":"Ren Fail"},{"key":"R23-15-20230811","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1525-139X.2011.00848.x","article-title":"Unexpectedly severe metabolic acidosis associated with sodium thiosulfate therapy in a patient with calcific uremic arteriolopathy.","volume":"24","author":"Selk","year":"2011","journal-title":"Semin Dial"},{"key":"R24-15-20230811","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrneph.2009.99","article-title":"Sodium thiosulfate in the treatment of calcific uremic arteriolopathy.","volume":"5","author":"Schlieper","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"R25-15-20230811","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1523-1755.2001.00803.x","article-title":"Risk factors and mortality associated with calciphylaxis in end-stage renal disease.","volume":"60","author":"Mazhar","year":"2001","journal-title":"Kidney Int"},{"key":"R26-15-20230811","first-page":"63","article-title":"Successful sodium thiosulphate treatment for recurrent calcium urolithiasis.","volume":"23","author":"Yatzidis","year":"1985","journal-title":"Clin Nephrol"},{"key":"R27-15-20230811","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/08860229009060727","article-title":"Sodium thiosulfate treatment of tumoral calcinosis in patients with end-stage renal disease.","volume":"12","author":"Kyriakopoulos","year":"1990","journal-title":"Ren Fail"},{"key":"R28-15-20230811","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000188861","article-title":"Sodium thiosulfate in the treatment of tumoral calcifications in a hemodialysis patient without hyperparathyroidism.","volume":"72","author":"Papadakis","year":"1996","journal-title":"Nephron"},{"key":"R29-15-20230811","first-page":"8","article-title":"Sodium thiosulfate-based treatment in calcific uremic arteriolopathy: A consecutive case series.","volume":"75","author":"Sood","year":"2011","journal-title":"Clin Nephrol"},{"key":"R30-15-20230811","doi-asserted-by":"crossref","first-page":"485","DOI":"10.5414\/CNP75485","article-title":"Efficacy of sodium thiosulfate for the treatment for calciphylaxis.","volume":"75","author":"Noureddine","year":"2011","journal-title":"Clin Nephrol"},{"key":"R31-15-20230811","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/ndt\/gfr375","article-title":"The chemistry of thiosulfate and vascular calcification.","volume":"27","author":"O\u2019Neill","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R32-15-20230811","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/ki.2008.455","article-title":"Sodium thiosulfate prevents vascular calcifications in uremic rats.","volume":"74","author":"Pasch","year":"2008","journal-title":"Kidney Int"},{"key":"R33-15-20230811","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/ndt\/gfr658","article-title":"A case-control study of calciphylaxis in Japanese end-stage renal disease patients.","volume":"27","author":"Hayashi","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R34-15-20230811","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1053\/j.ajkd.2011.06.022","article-title":"Multi-intervention management of calciphylaxis: A report of 7 cases.","volume":"58","author":"Baldwin","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"R35-15-20230811","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1525-139X.2005.00082.x","article-title":"Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphylaxis.","volume":"18","author":"Brucculeri","year":"2005","journal-title":"Semin Dial"},{"key":"R36-15-20230811","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1300\/J045v08n01_05","article-title":"The effects of non-response on statistical inference.","volume":"8","author":"Jones","year":"1996","journal-title":"J Health Soc Policy"},{"key":"R37-15-20230811","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1053\/j.ajkd.2006.04.073","article-title":"Identification and referral of patients with progressive CKD: A national study.","volume":"48","author":"Boulware","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"R38-15-20230811","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2215\/CJN.09671010","article-title":"Simulation-based sodium thiosulfate dosing strategies for the treatment of calciphylaxis.","volume":"6","author":"Singh","year":"2011","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201307000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:43:12Z","timestamp":1786369392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201307000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.09880912","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718189990.793487588","asserted-by":"object"}]},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}